For research use only. Not for therapeutic Use.
BET bromodomain inhibitor is a potent BET inhibitor extracted from patent WO/2015/153871A2, compound example 11.
| Catalog Number | I013207 |
| CAS Number | 1505453-59-7 |
| Synonyms | 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(1-methylpyrazol-4-yl)-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide |
| Molecular Formula | C24H20ClN5O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C24H20ClN5O2/c1-13-22-18-8-5-15(16-11-27-30(2)12-16)9-19(18)23(14-3-6-17(25)7-4-14)28-20(10-21(26)31)24(22)32-29-13/h3-9,11-12,20H,10H2,1-2H3,(H2,26,31)/t20-/m0/s1 |
| InChIKey | QFLGNZXBWIQDLQ-FQEVSTJZSA-N |
| SMILES | CC1=NOC2=C1C3=C(C=C(C=C3)C4=CN(N=C4)C)C(=NC2CC(=O)N)C5=CC=C(C=C5)Cl |
| Reference | [1]. WO/2015/153871A2 |
